Massively parallel, computationally guided design of a proenzyme
Open Access
- 4 April 2022
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 119 (15)
Abstract
Significance: Proteins have shown promise as therapeutics and diagnostics, but their effectiveness is limited by our inability to spatially target their activity. To overcome this limitation, we developed a computationally guided method to design inactive proenzymes or zymogens, which are activated through cleavage by a protease. Since proteases are differentially expressed in various tissues and disease states, including cancer, these proenzymes could be targeted to the desired microenvironment. We tested our method on the therapeutically relevant protein carboxypeptidase G2 (CPG2). We designed Pro-CPG2s that are inhibited by 80 to 98% and are partially to fully reactivatable following protease treatment. The developed methodology, with further refinements, could pave the way for routinely designing protease-activated protein-based therapeutics and diagnostics that act in a spatially controlled manner.Keywords
All Related Versions
Funding Information
- HHS | National Institutes of Health (GM132565)
- National Science Foundation (MCB1716623)
- Gouvernement du Canada | Canadian Institutes of Health Research (PostdocFellowship)
- HHS | NIH | National Institute of General Medical Sciences (T32GM135141)
This publication has 51 references indexed in Scilit:
- Glucarpidase to combat toxic levels of methotrexate in patientsTherapeutics and Clinical Risk Management, 2012
- Protease-Activated Drug DevelopmentTheranostics, 2012
- Characterizing flexible and intrinsically unstructured biological macromolecules by SAS using the Porod‐Debye lawBiopolymers, 2011
- Development of an attenuated interleukin-2 fusion protein that can be activated by tumour-expressed proteasesImmunology, 2011
- PC3 is a cell line characteristic of prostatic small cell carcinomaThe Prostate, 2011
- Crystal Structure of Staphylococcus aureus Metallopeptidase (Sapep) Reveals Large Domain Motions between the Manganese-bound and Apo-statesJournal of Biological Chemistry, 2010
- Engineering an artificial zymogen by alternate frame protein foldingProceedings of the National Academy of Sciences, 2010
- Multiple Conformers in Active Site of Human Dihydrofolate Reductase F31R/Q35E Double Mutant Suggest Structural Basis for Methotrexate ResistanceJournal of Biological Chemistry, 2009
- Design and Characterization of an HIV-Specific Ribonuclease ZymogenAIDS Research and Human Retroviruses, 2008
- CRYSOL– a Program to Evaluate X-ray Solution Scattering of Biological Macromolecules from Atomic CoordinatesJournal of Applied Crystallography, 1995